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Objectives: To investigate the characteristics, trends in management (permissive hypercapnia;
mechanical ventilation (MV); neuromuscular blockade) and their impact on complications and
outcomes in Status Asthmaticus (SA).
Methods: We performed a retrospective observational study of subjects admitted with SA to
a single multidisciplinary MICU over a 30-year period. All laboratory, radiologic, respiratory
care, physician notes and orders were extracted from an electronic medical record (EMR)
maintained during the entire duration of the study.
Results: Two hundred and twenty-seven subjects were admitted with 280 episodes of SA.
While subjects reflected our regional population (52% Hispanic), African Americans were
over-represented (22%) and Caucasians under-represented (21%). Thirty-eight percent re-
ported childhood asthma, 27% were steroid dependent (10% in the last 10 years), and 18%
had a recent steroid taper. One hundred and thirty-nine (61.2%) required intubation. The dura-
tion of hospitalization was similar between mechanically ventilated and non-ventilated
subjects (5.8 4.41 vs. 6.8 7.22 days; pZ 0.07). The overall complication rate remained
low irrespective of the use of permissive hypercapnia or mode of mechanical ventilation (over-
all mortality 0.4%; pneumothorax 2.5%; pneumonia 2.9%). The frequency of SA declined signif-
icantly in the last 10 years of the study (12.4 vs. 3.2 cases/year).iversity of Texas Health Science Center at San Antonio and the University Health Systems Hospital,
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Status asthmaticus in the medical intensive care unit 345Conclusions: Despite the frequent use of mechanical ventilation, mortality/complication rates
remained extremely low. MV did not significantly increase the duration of hospitalization. At
our institution, the frequency of SA significantly decreased despite an increase in emergency
room visits for asthma.
Published by Elsevier Ltd.Introduction
Status asthmaticus (SA) is a life-threatening condition char-
acterized by progressive respiratory failure due to asthma
that is unresponsive to standard therapeutic measures.1
While overall mortality from asthma has failed to decline,
there is minimal literature regarding the outcome of SA once
patients reach the ICU.2e6 Most investigators report
mortality rates of 6e38% with more recent studies reporting
mortality less than 10%.7,8 Several reports suggest that
mechanical ventilation (MV) in SA is associated with signifi-
cant morbidity and mortality.9e12 Many patients admitted
with SA will require ICU level care. Severe bronchocon-
striction, mucous plugging, and air trapping make these
patients challenging to manage, and optimal treatment
strategies have not yet been delineated.4 In particular,
ventilator strategies and complication rates are not well
defined. However, the NAEPP guidelines suggest that
“permissive hypercapnia” or “controlled hypoventilation”
should be utilized to reduce the risk of barotrauma.13 The
goal of the present study was to characterize the clinical
course of subjects with SA being treated in the ICU. To our
knowledge, this study represents the largest reported series
of SA in the literature. Our data span three decades, allowing
a unique opportunity to study changes in prevalence,
outcomes, and treatment strategies in SA.
Materials and methods
This study involves a retrospective review of 280 hospital
admissions in 227 patients admitted to the medical ICU of
the University of Texas Health Science Center e San Anto-
nio between December 1980 through January of 2010 with
severe exacerbation of asthma. The University Hospital is
a 650 bed, urban, academic hospital located in San Antonio,
Texas. The MICU is a 20-bed unit providing care for critically
ill medical patients. An electronic medical record allowed
for data collection including age, race, sex, use and type of
MV, laboratory and radiographic reports, length of hospital
stay, complications, and mortality.
All patients met the American Thoracic Society criteria
for the diagnosis of asthma. Patient with a 10-pack year
history of cigarette use or greater were excluded. Patients
were considered to have recurrent SA if they had any prior
ICU admissions for exacerbation of asthma. Adult-onset
asthma was characterized as asthma that developed after
age 17. A recent steroid taper was defined as oral cortico-
steroids within four weeks prior to admission.
Decisions regarding invasive or non-invasive ventilation
were based on the judgment of the emergency department
(ED) or ICU attending physician. In the first two decades
most patients were treated with tidal volumes of
10e12 ml/kg. In the last decade low tidal volume strategieswith permissive hypercapnia were exclusively employed.
Ventilatory modes and settings were left to the discretion
of the ICU attending. The use of neuromuscular blockers in
SA patients is discouraged at our institution unless neces-
sary for intubation or to allow ventilator synchrony.
This research protocol was approved by the IRB of The
University of Texas Health Science Center at San Antonio (#
HSC20100125E). Statistical analysis was performed using
Stata Statistical Software, version 9.3 (Stata Corp, College
Station, Texas). Comparisons between groups were made
using Student’s t test, Fischer’s Exact Test, and analysis of
variance (ANOVA). Results are expressed asmean standard
deviation. All p-values <0.05 were considered significant.Results
Between 1980 and 2010, 227 patients were admitted to the
MICU with 280 episodes of SA. The average age of our
population was 37.3 14.87 years (range 16e77), with 147
(65%) female patients and 80 (35%) male patients. Ethnic
groups included 118 (52%) Hispanic, 51 (22%) African
American, 48 (21%) Caucasian and 12 (5%) others. The
average age of asthma onset was 37.3 14.9 years and 62%
of all patients had adult-onset asthma. Recurrent SA was
noted in 34 patients, yielding a rate of 15%. Among patients
with recurrent disease, 20 had 2 episodes, 10 had 3
episodes, three had 4 episodes, and one had 5 episodes.
Overall, 62 (27%) were steroid dependent, yet only 3/32
(9%) studied in the past 10 years were steroid dependent. A
recent steroid taper was reported in 41 patients (18%)
(Table 1).
The overall duration of asthma symptoms prior to
admission was 3.65 2.81 days, and duration of hospitali-
zation was 5.77 3.81 days. In our series, 139 patients
(61.2%) required intubation and mechanical ventilation and
3 (1%) required non-invasive positive pressure ventilation.
Length of time on MV was 3.42 days (range 8 h to 12 days),
however, duration of hospitalization was not different
between groups. Table 2 outlines differences in length of
hospital stay, peak pCO2, lowest pH, and duration of
symptoms between ventilated and non-ventilated patients.
The mode of ventilation and tidal volume varied greatly
depending on the time period of the study. During the first
20 years, most patients (111/117) were treated with
synchronized intermittent mandatory ventilation (SIMV);
the remaining with assist control (ACV) or pressure control
ventilation (PCV). During this time period, the average tidal
volume was 725 ml (range 600e1000 ml) and peak pressures
averaged 46.5 cm H2O (range 20e107 cm H2O). Only two
patients were treated with PCV, both with poor outcomes
(one acute myocardial infarction and death, another with
anoxic brain injury). In the last 10 years, the majority
(16/22) lof patients were treated with continuous
Table 1 Demographics and characteristics of subjects
with SA (nZ 227).
Variable Data
Ageae yrs 37.3 14.87
(range 16e77)
Sex e no. (%)
Male 80 (35%)
Female 147 (65%)
Ethnicity e no. (%)
Hispanic 118 (52%)
African American 51 (22%)
Caucasian 48 (21%)
Others 10 (4%)
Childhood asthma onsetb 86 (38%)
Recurrent episodes
Subjectse no. (%) 34 (15%)
Episodes e no. (%)c 53 (19%)
Oral corticosteroids use e no. (%)
Steroid dependent 62 (27%)
Recent steroid taperd 41 (18%)
a Data are presented as mean SD or no. (%).
b Asthma onset before 17 yrs of age.
c Total 53 recurrent episodes in 34 subjects: 20 (2 episodes);
10 (3 episodes); 3 (4episodes); and 1 (5 episodes).
d Oral corticosteroid tapering within 4 weeks from SA.
346 J.I. Peters et al.mechanical ventilation (AC/CMV). SIMV was utilized in only
four patients and PCV was used in the remaining two.
Extrapolating from controlled hypoventilation data that
was published during this time period, patients in the last
10 years were treated with lower tidal volumes. The
average tidal volume in the more recent cohort was 545 ml
(range 450e640 ml). The rate of neuromuscular blockade in
intubated subjects was significantly greater during the last
10 years (9/22 or 41%) vs. the first 20 years (12/117 or 10%;
p< 0.05).
Complication rates were low despite the large
percentage of patients requiring MV. The mortality rate
over 30 years was 0.35% (1/280) based on episodes of SA
and 0.4% (1/227) based on number of patients. No patients
died as a direct result of SA. The one fatality that was
observed was in a patient who developed an acute
myocardial infarction possibly related to acute respiratoryTable 2 Differences in characteristics between intubated and
Characteristics Non-intubated
Age e yrs 36.0 13.9
Ethnicity e no. (%)
Hispanic 50
African American 12
Caucasian 15
Duration of symptoms e days 4.13 3.92
Peak pCO2 e (Torr) 40.55 12.6
Lowest pH 7.36 0.11
Hospitalization duration e days 5.3 3.4acidosis. After anticoagulation, the patient developed
massive GI bleeding and cardiopulmonary arrest 2 days
after his asthma exacerbation resolved. Other major
complications included 1 case of anoxic encephalopathy
(0.4%), 6 myocardial infarctions (2.1%), 15 episodes of
hypotension (5.4%), and 8 cases of pneumonia (2.9%). Less
severe complications such as hyperglycemia were initially
seen in 46% patients in the first part of the study but
subsequently reduced to 18%. In addition, electrolyte
abnormalities were frequent and hypokalemia was seen in
35% of patients and hypophosphatemia was noted in 17%.
Pneumothorax occurred in 7/280 episodes of SA (2.5%), 3 of
these cases occurred in the ED prior to MV. No cases of
pneumothorax were identified in the more recent cohort,
where smaller tidal volumes were employed. Table 3
highlights differences in complication rates between the
first and second portions of the study.
Discussion
The management of SA in the MICU has evolved in recent
years despite a lack of randomized controlled trials to guide
optimal therapy in these patients. The present study is
unique in that it was conducted over a 30-year time period.
The long-term nature of our study provides valuable infor-
mation regarding the impact of recent trends in asthma
management including permissive hypercapnia, avoidance
of neuromuscular blockade, and the preferential use of
assist control ventilation.
The demographics of our subjects with SA are in agree-
ment with prior observations that note SA is more common
in female patients and more common in African Americans.
Sixty-five percent of our subjects were female and African
American subjects were over-represented (22% vs. 6% in our
patient population). Little data exist regarding the onset of
asthma in subjects with SA and our study found the average
age of onset of asthma to be 37.3 14.9 years with 62% of
subjects being identified with adult-onset asthma. One
important finding in our study was the incidence of subjects
presenting with recurrent SA (15%) and supports the
concept that prior ICU admission for severe asthma is
a major risk factor for life-threatening asthma.13 Addi-
tionally, exacerbation of asthma while receiving steroids or
after a recent steroid taper should be assessed in the ED
since 18% of our subjects presented during or after a steroid
taper.non-intubated patients.
Intubated p-Value
38.2 13.5 pZ 0.37
68 (58%)
39 (76%)
33 (69%)
3.04 2.9 pZ 0.06
60.54 18.1 p 0.001
7.21 0.15 pZ 0.01
6.8 4.21 pZ 0.07
Table 3 Complications of status asthmaticus.
Variable Number (%)
First 20 yrs
(1980e1999), nZ 248
Last 10 yrs
(2000e2009), nZ 32
Overall 30 yrs
(1980e2009), nZ 280
Deatha 1 (0.4%) 0 1 (0.4%)
Anoxic encephalopathy 1 (0.4%) 0 1 (0.4%)
Pneumothorax 7 (2.8%) 0 7 (2.5%)
Myocardial infarction 4 (1.6%) 2 (6.3%) 6 (2.1%)
Hypotension 12 (4.8%) 3 (9.4%) 15 (5.4%)
Pneumonia 5 (2.0%) 3 (9.4%) 8 (2.9%)
Hypokalemia 89 (35%) 9 (28%) 98 (35%)
Hypophosphatemia 45 (18%) 3 (9.4%) 48 (17%)
Hyperglycemiab 114 (46%) 6 (18%) 120 (43%)
a From myocardial infarction with secondary massive GI after anticoagulation.
b Glucose over 150 mg/dl.
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the overallmortality rate in SA has declined significantly from
early reports.3,6,14 As seen in previous studies, most deaths in
patientswith SAare related to secondarycomplications in the
MICU or failure to receive appropriate care rather than
refractory asthma itself.8 Some authors have concluded that
the historically high morbidity andmortality rates associated
with severe asthma were related to complications from MV.3
It has also been suggested that controlled hypoventilation
strategies are a primary cause of improvements in clinical
outcomes.6,15 Surprisingly, mortality rates did not differ
between the earlier cohorts in which larger tidal volumes
were employed compared to the more recent cohort which
relied on permissive hypercapnia. Though the preferential
use of assist control ventilation and permissive hypercapnia
are widely accepted practices,16 this strategy of MV did not
have a significant impact on mortality in the present study
and this study was unable to establish clear benefit or harm
related to the use of permissive hypercapnia.
The decision to use AC/CMV or SIMV modes of ventilation
is perhaps even more controversial. Our study found no
difference in outcomes between these two modes of
ventilation. The use of PCV was not well studied in our
population but was associated with poorer outcomes in our
study, as the two most serious complications during the
study (death and anoxic brain injury) occurred in these
patients. It is not clear whether the complications were
related to the choice of ventilator mode, or if the use of
PCV served as a marker for patients who were more
severely ill. The successful use of PCV has been reported in
a recent pediatric study of SA.17 Based on the current study
the use of either AC/CMV or SIMV ventilator modes seem to
be reasonable choices, and we recommend avoiding PCV
until this mode of ventilation is studied in adults with SA.
Adequate oxygenation, avoidance of dynamic hyperinfla-
tion, and close attention to inspiratory flow rates, I/E ratio,
and plateau pressures are likely far more important prin-
ciples than the mode of ventilation utilized.
The use of neuromuscular blockade (NMB) in subjects
intubated for SA is strongly discouraged. Leatherman et al.
found an incidence of muscle weakness in asthmatic
patients treated with NMB and steroids of 29%.18,19 A study
by Adnet et al. evaluated the morbidity of intubated
asthmatic patients receiving long-term (greater than 12 h)neuromuscular blockade in a retrospective cohort study
from five centers.19 The occurrence of ventilator associated
pneumonia, post-intubation myopathy, and duration of ICU
stay was significantly higher in the neuromuscular blockade
group. Additionally, multiple logistic regressions showed
that neuromuscular blockade was the only independent
predictor of overall morbidity and occurred in 18% in the
neuromuscular group vs. 2% in the steroid only group. In our
study neuromuscular blockade was predominately used at
the time of intubation and only three subjects received
neuromuscular blockade for greater than 12 h. Our overall
rate of myopathy in subject receiving neuromuscular
blockade of 19% (data not shown) was similar to that re-
ported by Adnet et al. A recent study by Kessler et al.,
demonstrated that the risk of myopathy in SA was not
correlated with the duration of NMB.20 Even subjects
receiving NMB for 2 h had a 14% incidence of clinically
significant weakness which was not significantly greater
than subjects receiving more than 24 h of NMB.
Among the other complications noted during our study,
electrolyte abnormalities were the most frequent (17e35%)
but were mild and well tolerated. Pneumonia occurred in
2.9% of patients, and was more commonly seen in the
recent cohort of patients (9.4% as compared to 2.0%).
Hypotension was noted in 5.4% of patients overall, with
a statistically significant increase during the last 10 years
(9.4% vs. 4.8%). Most episodes of hypotension occurred
immediately post-intubation and the duration of hypoten-
sion was generally very short. Complications in the imme-
diate postintubation period are well described and
dysrrhythmias or hypotension occurred in 10% of subjects in
the report by Zimmerman et al.21 Early studies reported the
risk of pnuemothorax between 10 and 30%22 but recent
studies suggest rates of 2e6%.8,21 Our study supports the
more recent studies since pneumothorax occurred in 7/280
episodes of SA (2.5%). Three of these cases occurred in the
ED prior to MV and were felt to be secondary to aggressive
bag valve mask resuscitation of the patients immediately
after intubation. No cases of pneumothorax were identified
in the more recent cohort, where smaller tidal volumes
were employed. Aside from pneumothorax, other serious
complications included death, anoxic encephalopathy, and
myocardial infarction. The rates for all severe complica-
tions, however, were low (ranging from 0.4% to 2.5%).
348 J.I. Peters et al.One of the most striking findings in our study is the sharp
decline in the occurrence of SA at our institution. From
1980 to 1999 our institution treated an average of 12.4 ICU
patients with SA per year. During 2000e2010 this number
dropped to 3.2 cases per year. It is well known that asthma
prevalence and hospitalization rates are both increasing
despite recent therapeutic advancements.23 The dramatic
reduction in SA seen at our institution is likely multifacto-
rial. Widespread use of inhaled corticosteroids, improved
access to care, and advancements in ED management of
asthma are factors that likely contributed to this decline.2,7
In support of this concept, a prospective asthma disease
management study from our institution revealed that
approximately 70% of asthmatics treated at our institution
comply with their inhaled corticosteroid therapy.24 Despite
the increasing prevalence of asthma, many patients who
receive timely and appropriate care can likely avoid
progression to SA.
Our study has several limitations. First, it is a single
institution study with a retrospective design. Second, due
to geographic location our population consisted primarily of
Hispanic patients, who may have milder disease than other
ethnic groups. As a result, it may be difficult to generalize
our findings to other populations. Additionally, it could be
argued that our extremely low mortality rate despite a high
incidence of MV represents unnecessary intubation in some
patients. We feel that this explanation is unlikely consid-
ering that the reasons for intubation included respiratory
arrest (19%), CO2 narcosis (4%), and progressive hyper-
capnia (52%). Only 25% of patients were intubated due to
clinical tiring without worsening hypercapnia. Further-
more, significantly higher pCO2 and lower pH values among
intubated patients suggest that these patients were more
acutely ill than those who avoided invasive MV.
In conclusion, our study demonstrates that outcomes for
SA should be good/excellent once patients reach the ICU.
Despite our frequent use of MV, mortality and complica-
tions remained low. Additionally, MV did not significantly
increase the duration of hospitalization.
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